News

The University of Wisconsin will take part in a clinical trial that involves investigation of patient’s own stem cells to treat severe coronary artery disease.

University of Oslo’s researchers have identified certain chemical marks to predict which stem cells in liposuctioned fat can actually regenerate tissue.

Millipore has acquired an exclusive worldwide license to distribute the ENStem neural progenitor cells derived from NIH-registered human embryonic stem cells.

A research study in mice at Rockfeller University shows that embryonic stem cells implanted in the brain appear to develop into fully differentiated granule neurons.

Both companies have signed a multi-year collaboration to jointly identify targets for the treatment of Alzheimer’s disease with the Research Institute of Molecular Pathology in Vienna.

Biosite will have access to Compugen’s diagnostic and immunoassay biomarkers under a renewed and expanded partnership and licensing agreement.

Carl Zeiss has acquired the equipment business of the US Company Clarient to strengthen its clinical cancer diagnostics and cancer research.

Stem Cell Sciences will use the system to culture several different human and mouse stem cell lines to supply the pharmaceutical companies with the right quantity and quality of cells in assay ready plates.

Medical College of Georgia researchers will use a test to measure a tumor's aggressiveness in more than 10,000 women to identify the patients who need chemotherapy.

Opaldia has launched the programme incorporating genetic testing, screening and information services to help patients make informed decisions on breast cancer concerns.